- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/078 - Cellules du sang ou du système immunitaire
Détention brevets de la classe C12N 5/078
Brevets de cette classe: 3221
Historique des publications depuis 10 ans
|
177
|
229
|
277
|
293
|
324
|
257
|
292
|
255
|
236
|
117
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 371 |
93 |
| Kyoto University | 2897 |
44 |
| Megakaryon Corporation | 50 |
37 |
| FATE Therapeutics, Inc. | 235 |
33 |
| Fenwal, Inc. | 700 |
31 |
| Rubius Therapeutics, Inc. | 62 |
31 |
| The Board of Trustees of the Leland Stanford Junior University | 6652 |
28 |
| The Regents of the University of California | 20694 |
26 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3215 |
24 |
| Cellphire, Inc. | 108 |
22 |
| The Trustees of the University of Pennsylvania | 4410 |
18 |
| University Health Network | 1059 |
18 |
| Massachusetts Institute of Technology | 10237 |
17 |
| President and Fellows of Harvard College | 6085 |
17 |
| Cellectis | 415 |
17 |
| Children's Medical Center Corporation | 1958 |
17 |
| Board of Regents, The University of Texas System | 6086 |
16 |
| The Trustees of Columbia University in the City of New York | 3638 |
16 |
| Memorial Sloan-Kettering Cancer Center | 2039 |
16 |
| The University of Tokyo | 4356 |
16 |
| Autres propriétaires | 2684 |